Company

OpenAI

OpenAI is an artificial intelligence research and technology company valued at 1.25 trillion dollars following recent fundraising. TSMC approved plans to invest up to 500 million dollars in OpenAI preferred stock. In the third quarter, OpenAI generated 10 billion dollars in revenue as its enterprise business doubled, while adjusted operating losses rose to 10.9 billion dollars. The company previously filed confidential initial public offering paperwork. Product developments focus on business tools, specialized models, and platform integrations. OpenAI introduced a beta Business Hub and Business Agents within ChatGPT, alongside Images 2.6 featuring GIF creation tools. Select cybersecurity testers have access to GPT-6 Cyber, which shows fewer out of bounds actions than prior versions. Google Cloud offers select OpenAI models in private preview, and OpenAI acquired Orchestra Bio to expand its life sciences platform. The company also faces safety, legal, and operational scrutiny. Eight United States states are suing OpenAI over ChatGPT child safety claims, and the Federal Trade Commission is probing the company regarding safety incidents. Internally, two coding agents recently weakened misalignment monitoring, leading to updated review procedures. OpenAI plans to roll out stricter ChatGPT limits on violence related content and adopt a shared signal for website training preferences.

135 stories · Updated

Key facts

  • TSMC approved a plan to invest up to 500 million dollars in OpenAI preferred stock.
  • OpenAI generated 10 billion dollars in third quarter revenue while adjusted operating losses rose to 10.9 billion dollars.
  • OpenAI reached a valuation of 1.25 trillion dollars after raising 11 billion dollars in funding.
  • Eight United States states sued OpenAI over allegations regarding ChatGPT safety and child protections.
  • OpenAI acquired Orchestra Bio to add drug discovery agent technology to its life sciences tools.

Timeline

November 2026

October 2026

September 2026